Skip to main content
logo
Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.20
-0.05 (-0.17%)
At close: Mar 27, 2026

TPEX:4111 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,7471,7621,5841,5191,5441,316
Market Cap Growth
4.82%11.23%4.32%-1.66%17.32%-3.55%
Enterprise Value
1,3271,3661,3131,2681,4251,261
Last Close Price
29.2029.4525.6923.7323.0718.87
PE Ratio
10.7410.7314.3222.1110.0316.30
PS Ratio
1.271.281.361.431.351.29
PB Ratio
1.271.281.241.251.261.20
P/TBV Ratio
1.271.281.241.251.261.20
P/FCF Ratio
9.679.7512.28-14.10-
P/OCF Ratio
6.366.427.4320.387.199.45
EV/Sales Ratio
0.960.991.131.201.251.23
EV/EBITDA Ratio
4.854.997.9510.296.506.61
EV/EBIT Ratio
6.666.8513.2720.719.2610.60
EV/FCF Ratio
7.347.5610.18-13.01-
Debt / Equity Ratio
0.020.020.020.100.110.13
Debt / EBITDA Ratio
0.090.090.161.000.570.73
Debt / FCF Ratio
0.130.130.21-1.17-
Net Debt / Equity Ratio
-0.30-0.30-0.24-0.21-0.27-0.10
Net Debt / EBITDA Ratio
-1.53-1.53-1.87-2.10-1.50-0.57
Net Debt / FCF Ratio
-2.32-2.32-2.409.57-2.990.86
Asset Turnover
0.750.750.660.600.660.65
Inventory Turnover
8.328.328.267.637.617.58
Quick Ratio
1.741.741.831.571.541.20
Current Ratio
2.012.012.111.781.781.46
Return on Equity (ROE)
12.37%12.37%8.87%5.63%15.44%9.90%
Return on Assets (ROA)
6.76%6.76%3.52%2.15%5.56%4.73%
Return on Invested Capital (ROIC)
16.66%16.44%8.25%5.19%16.31%11.15%
Return on Capital Employed (ROCE)
13.50%13.50%7.20%4.70%11.70%9.80%
Earnings Yield
9.40%9.32%6.98%4.52%9.97%6.13%
FCF Yield
10.35%10.26%8.14%-1.78%7.09%-9.54%
Dividend Yield
3.26%-3.71%4.01%4.95%5.05%
Payout Ratio
34.69%34.69%51.51%99.57%37.00%70.57%
Buyback Yield / Dilution
-0.40%-0.40%-0.12%0.16%-0.06%-0.10%
Total Shareholder Return
2.86%-0.40%3.59%4.17%4.89%4.95%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.